Disrupt CAD III With the Shockwave Coronary IVL System
Recruiting
18 years - 99 years
All
Phase
N/A
1 Location
Brief description of study
The study design is a prospective, multicenter, single-arm, global IDE study to evaluate the safety and effectiveness of the Shockwave Medical Coronary Intravascular Lithotripsy (IVL) System in de novo, calcified, stenotic coronary arteries prior to stenting. Disrupt CAD III is being conducted as a staged pivotal study.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: coronary artery disease
-
Age: 18 years - 99 years
-
Gender: All
Male and Female, 18 or older native coronary artery disease
Updated on
04 Aug 2024.
Study ID: 832568